Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Determinants of Infant Immunity to Pertussis
NCT05856396Phase 4Completed
- Sponsor
- Saint-Pierre University Hospital
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of diphtheria, tetanus, and acellular pertussis vaccine, DTaP-IPV-Hep B-PRP-T vaccine in pertussis, sponsored by Saint-Pierre University Hospital. Started Sep 2023; status: completed.
02
Drugs
diphtheria, tetanus, and acellular pertussis vaccineDTaP-IPV-Hep B-PRP-T vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT05856396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05856396.